Showing results (261-270 of 318) with videos related to

Sort By:
Pageof 32
BMC Complementary and Alternative Medicine|July 3, 2017
Effects of Bu Shen Yi sui capsule on NogoA/NgR and its signaling pathways RhoA/ROCK in mice with experimental autoimmune encephalomyelitisLing Fang, Yongqiang Wang, Qi Zheng, et al.
Environmental Science & Technology|May 26, 2026
Photochemical Aging of China VI Gasoline Vehicle Exhaust Drives Nonlinear Secondary Aerosol FormationJunling Li, Xinping Yang, Yufei Song, et al.
Frontiers in Pharmacology|August 6, 2019
The Bu Shen Yi Sui Formula Promotes Axonal Regeneration via Regulating the Neurotrophic Factor BDNF/TrkB and the Downstream PI3K/Akt Signaling PathwayQi Zheng, Lei Liu, Haolong Liu, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2003
Indole amide hydroxamic acids as potent inhibitors of histone deacetylasesYujia Dai, Yan Guo, Jun Guo, et al.
Food & Function|November 16, 2021
Type 3 resistant starch from Canna edulis modulates obesity and obesity-related low-grade systemic inflammation in mice by regulating gut microbiota composition and metabolismJiahui Wu, Minyi Qiu, Chi Zhang, et al.
Translational Oncology|November 22, 2020
Genomic profile and immune microenvironment in patients with relapsed stage IA lung adenocarcinomaLu Yang, Jing Zhang, Yane Song, et al.
Molecular Cancer Research : MCR|December 19, 2022
Evolutionary Characteristics and Immunologic Divergence of Lung and Brain Metastasis Lesions in NSCLCTongji Xie, Zhenghao Liu, Yan Li, et al.
Cancer Medicine|March 20, 2016
A prognostic model for platinum-doublet as second-line chemotherapy in advanced non-small-cell lung cancer patientsHongnan Mo, Xuezhi Hao, Yutao Liu, et al.
BMC Medicine|August 28, 2022
Pyrotinib combined with apatinib for targeting metastatic non-small cell lung cancer with HER2 alterations: a prospective, open-label, single-arm phase 2 study (PATHER2)Guangjian Yang, Haiyan Xu, Yaning Yang, et al.
Frontiers in Oncology|November 1, 2021
The Sequence of Intracranial Radiotherapy and Systemic Treatment With Tyrosine Kinase Inhibitors for Gene-Driven Non-Small Cell Lung Cancer Brain Metastases in the Targeted Treatment Era: A 10-Year Single-Center ExperienceSiran Yang, Jianping Xiao, Qingfeng Liu, et al.
Pageof 32